Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus sevoflurane for immune effects during fiberoptic bronchoscopy in children with severe Mycoplasma pneumoniae pneumonia
ChiCTR1900022050Phase 4Not yet recruiting
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Mycoplasmal pneumonia comparing Sevoflurane group with Propofol group (2 arms). Primary endpoints: CD3+ T cells, CD4+ T cells and 3 more. Planned start May 2019; status: not yet recruiting.
02
Drugs
propofolsevoflurane
03
Conditions
Mycoplasmal pneumonia
Beyond the preview
Go deeper on ChiCTR1900022050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022050.